Trademark: 86606877
Word
SATIVOL
Status
Dead
Status Code
601
Status Date
Wednesday, June 28, 2017
Serial Number
86606877
Mark Type
4000
Filing Date
Wednesday, April 22, 2015
Abandoned Date
Tuesday, June 27, 2017

Trademark Owner History
UNITED GREENERIES HOLDINGS LTD. - 1st New Owner Before Publication
MMJ Bioscience Inc. - Original Applicant

Classifications
31 cannabidiol (CBD) derived from industrial hemp for use in the manufacture of pharmaceuticals; soluble films for use in the manufacture of delivery agents for pharmaceuticals and vitamins; consumer products, namely, body care, skin care, hair care, cosmetics, and personal care products based on CBD derived from industrial hemp, namely, creams, oils, emollients, ointments, rubs, lotions, salves, shampoos, conditioners, hair treatments, scrubs, tonners, masks, drops, oils body wash, butters, exfoliants, moisturizers, and gels; pharmaceuticals, pharmaceutical preparations, and nutraceuticals for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; Dietary and nutritional supplements containing cannabidiol (CBD); pharmaceuticals, pharmaceutical preparations, and nutraceuticals containing CBD derived from industrial hemp for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; nutritional and dietary supplements; food supplements; medicines containing CBD derived from industrial hemp for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, Multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; magnetically encoded cards, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; magnetically encoded identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; consumer products, namely, edible oils; consumer products, namely, non-alcoholic beverages, namely, soft drinks, fruit drinks, vegetable drinks, and juices; consumer products, namely, smokeless vaporizer pipes and pens; online retail store wholesale services featuring CBD based pharmaceutical and body care products derived from industrial hemp; mail order buying clubs in the field of pharmaceutical products; membership services, namely, the operation and maintenance of an association promoting the interests of retail and wholesale stores in the field of medical marihuana; membership services, namely, providing discounts and processing rebates for the goods and services of others in the medical marijuana industry; retail and wholesale store services featuring CBD based pharmaceutical products derived from industrial hemp; retail and wholesale store services featuring pharmaceuticals containing CBDs; promoting the goods and services of others by issuance of rewards cards related to the purchase of CBD based products; retail and wholesale store reward programs to promote the sale of pharmaceuticals containing CBDs; providing a customer loyalty program which promotes the goods and services of others by offering rewards, bonus points or discount offers; providing consumer information in the field of medical marijuana; providing a website featuring commercial information regarding medical marijuana dispensaries; providing a website featuring information regarding political and business information regarding the medical marijuana and cannabis industries; providing discounts and processing rebates for retail stores and wholesale stores in the medical marijuana field; assembly of pharmaceuticals for others; customized production of pharmaceuticals, pharmaceutical products, nutraceuticals and CBD based products derived from industrial hemp; extraction of CBD derived from industrial hemp; scientific research services in the area of CBD based products derived from industrial hemp; product development services for products containing CBD based products derived from industrial hemp; research and development of products containing CBDs for others for clinical studies; providing a website featuring information regarding scientific and medical research in the field of cannabis and medical marijuana; operation of a web site that provides online social networking; providing a website featuring legal information regarding marijuana, cannabis and CBDs based products derived from industrial hemp

Trademark Events
Jun 28, 2017
Abandonment Notice Mailed - Express Abandonment
Jun 28, 2017
Abandonment - Express Mailed
Jun 27, 2017
Teas Express Abandonment Received
May 31, 2017
Notification Of Letter Of Suspension E-Mailed
May 31, 2017
Letter Of Suspension E-Mailed
May 31, 2017
Suspension Letter Written
May 11, 2017
Teas/Email Correspondence Entered
May 11, 2017
Correspondence Received In Law Office
May 9, 2017
Teas Response To Suspension Inquiry Received
Feb 8, 2017
Automatic Update Of Assignment Of Ownership
Jan 12, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 12, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 9, 2016
Notification Of Inquiry As To Suspension E-Mailed
Nov 9, 2016
Inquiry To Suspension E-Mailed
Nov 9, 2016
Suspension Inquiry Written
Oct 18, 2016
Lie Checked Susp - To Atty For Action
Apr 1, 2016
Notification Of Letter Of Suspension E-Mailed
Apr 1, 2016
Letter Of Suspension E-Mailed
Apr 1, 2016
Suspension Letter Written
Mar 4, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 4, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 4, 2016
Teas/Email Correspondence Entered
Mar 4, 2016
Correspondence Received In Law Office
Feb 26, 2016
Assigned To Lie
Feb 19, 2016
Teas Change Of Correspondence Received
Feb 19, 2016
Teas Response To Office Action Received
Aug 19, 2015
Notification Of Non-Final Action E-Mailed
Aug 19, 2015
Non-Final Action E-Mailed
Aug 19, 2015
Non-Final Action Written
Aug 4, 2015
Assigned To Examiner
May 20, 2015
Assigned To Examiner
May 20, 2015
Assigned To Examiner
May 1, 2015
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24